trans-4-(3-oxomorpholinyl)cyclohexanecarboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: trans-4-(3-oxomorpholinyl)cyclohexanecarboxylic acid
• 英文别名: trans-4-(3-oxomorpholin-4-yl)cyclohexanecarboxylic acid；4-(3-Oxo-morpholin-4-yl)-cyclohexanecarboxylic acid；4-(3-oxomorpholin-4-yl)cyclohexane-1-carboxylic acid
• 化学式: C₁₁H₁₇NO₄
• 分子量: 227.26
• InChiKey: PYUCPAGYOOYTBE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  trans-4-(3-oxomorpholinyl)cyclohexanecarboxylic acid 在 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 生成 4-(3-Oxomorpholin-4-yl)cyclohexane-1-carbonyl chloride
  参考文献：
  名称：

  [EN] AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS
  [FR] DÉRIVÉS D'AMIDE EN TANT QUE LIGANDS DU RÉCEPTEUR DE NEUROPEPTIDE Y5

  摘要：

  公开号：

  WO2010108052A3
• 作为产物：
  描述：

  4-[(2-chloro-acetyl)-(2-hydroxy-ethyl)-amino]-cyclohexanecarboxylic acid ethyl ester 在 sodium hydride 、 sodium hydroxide 、 盐酸 作用下， 以 四氢呋喃 、 mineral oil 、 甲醇 、 水 为溶剂， 反应 0.33h， 以78.4%的产率得到trans-4-(3-oxomorpholinyl)cyclohexanecarboxylic acid
  参考文献：
  名称：

  [EN] AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS
  [FR] DÉRIVÉS D'AMIDE EN TANT QUE LIGANDS DU RÉCEPTEUR DE NEUROPEPTIDE Y5

  摘要：

  公开号：

  WO2010108052A3

文献信息

• Fused furan compound
  申请人：Kawaguchi Takayuki

  公开号：US20060094724A1

  公开（公告）日：2006-05-04

  The present invention provides a condensed furan compound of the formula (I): wherein Ring X is benzene, pyridine, or the like; Y is an optionally substituted amino, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted saturated heterocyclic group, an optionally substituted unsaturated heterocyclic group; A is a single bond, lower alkylene, lower alkenylidene, lower alkenylene or an oxygen atom; R 3 is hydrogen or the like; and, R 4 is hydrogen, or the like, or pharmaceutically acceptable salts thereof, which is useful as a medicament, particularly, as an activated blood coagulation factor X inhibitor.

  本发明提供了式(I)的紧凑呋喃化合物：其中环X是苯、吡啶或类似物；Y是可选取代的氨基、可选取代的环烷基、可选取代的芳基、可选取代的饱和杂环基、可选取代的不饱和杂环基；A是单键、低级烷基、低级烯基亚烷基、低级烯基亚烯基或氧原子；R3是氢或类似物；R4是氢或类似物，或其药学上可接受的盐，其用作药物，特别是作为激活的血凝血酶X抑制剂。
• Benzofuran derivative
  申请人：Kawaguchi Takayuki

  公开号：US20050282808A1

  公开（公告）日：2005-12-22

  The present invention provides a benzofuran derivative of the formula [1]: wherein x is a group of the formula: —N═ or —CH═; Y is an optionally substituted amino group, an optionally substituted cycloalkyl group or an optionally substituted saturated heterocyclic group; A is a single bond, a carbon chain optionally having a double bond within or at the end(s) of the chain, or an oxygen atom; R 1 is a hydrogen atom or a halogen atom; Ring B is an optionally substituted benzene ring; and R 3 is a hydrogen atom, or a pharmaceutically acceptable salt thereof, which is useful as a medicament, especially as an activated blood coagulation factor X inhibitor.

  本发明提供了一种苯并呋喃衍生物，其化学式为[1]：其中x是公式：—N═或—CH═的基团；Y是可选取的取代氨基、可选取的取代环烷基或可选取的饱和杂环基团；A是单键、可选取的具有双键或位于链的末端的碳链或氧原子；R1是氢原子或卤素原子；环B是可选取的取代苯环；R3是氢原子或其药学上可接受的盐，该化合物作为药物特别是激活的血凝血因子X抑制剂。
• Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
  申请人：Seki Masahiko

  公开号：US20060173188A1

  公开（公告）日：2006-08-03

  The present invention provides a process of preparing a compound of the formula [I]: wherein X is a group of the formula: —N═ or —CH═; R 1 is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a cyano group or an amino group optionally substituted by a lower alkyl group; Ring A is a nitrogen-containing heterocyclic group; Ring B is an optionally substituted benzene ring or an optionally substituted pyridine ring; and R 3 is a hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof, which is useful as an inhibitor of activated blood coagulation factor X.

  本发明提供了一种制备式[I]化合物的方法：其中X是公式：—N═或—CH═ 的基团；R1是氢原子、卤素原子、低烷基、低烷氧基、氰基或者是可选择被低烷基取代的氨基基团；环A是含有氮杂环基团；环B是可选择被取代的苯环或者是可选择被取代的吡啶环；R3是氢原子或者是低烷基，或者其药学上可接受的盐，该化合物是一种活化血凝因子X抑制剂。
• PROCESS FOR PREPARING 3-ACYLAMINOBENZOFURAN-2-CARBOXYLIC ACID DERIVATIVE
  申请人：SEKI Masahiko

  公开号：US20090023918A1

  公开（公告）日：2009-01-22

  The present invention provides a process of preparing a compound of the formula [I]: wherein X is a group of the formula: —N═ or —CH═; R 1 is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a cyano group or an amino group optionally substituted by a lower alkyl group; Ring A is a nitrogen-containing heterocyclic group; Ring B is an optionally substituted benzene ring or an optionally substituted pyridine ring; and R 3 is a hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof, which is useful as an inhibitor of activated blood coagulation factor X.

  本发明提供了一种制备式[I]化合物的方法：其中X是公式：—N═或—CH═的基团；R1是氢原子、卤素原子、低碳基、低烷氧基、氰基或者是经低碳基取代的氨基基团；环A是含氮杂环基团；环B是可选取代的苯环或者是可选取代的吡啶环；R3是氢原子或者是低碳基，或者是其药学上可接受的盐，其可用作活化的血凝因子X的抑制剂。
• Amide type carboxamide derivative
  申请人：Kawaguchi Takayuki

  公开号：US20060287329A1

  公开（公告）日：2006-12-21

  The present invention provides an amide-type carboxamide derivative of the formula [1]: wherein X is a group of the formula: —N═ or the formula: —CH═; R 1 is a halogen atom, a lower alkyl group, and the like; R 2 is a group of the formula: and the like; Y 1 and Y 2 are the same or different and each is a group selected from a halogen atom, a lower alkyl group, a lower alkoxy group, and the like; Ring A is phenyl group, and the like, or a pharmaceutically acceptable salt thereof, which is useful as an inhibitor of FXa.

  本发明提供了一种式[1]的酰胺型羧酰胺衍生物，其中X是式：—N═或式：—CH═的基团；R1是卤素原子、低烷基等；R2是式：及类似基团；Y1和Y2相同或不同，每个都是从卤素原子、低烷基、低烷氧基等中选择的基团；环A是苯基等，或其药学上可接受的盐，可用作FXa抑制剂。